Oral And Vaginal Misoprostol 800 Microg Every 8 H For Early Abortion
Maybe your like
The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation- Clipboard
- My Bibliography
- Collections
- Citation manager
Save citation to file
Format: Summary (text) PubMed PMID Abstract (text) CSV Create file CancelEmail citation
Email address has not been verified. Go to My NCBI account settings to confirm your email and then refresh this page. To: Subject: Body: Format: Summary Summary (text) Abstract Abstract (text) MeSH and other data Send email CancelAdd to Collections
- Create a new collection
- Add to an existing collection
Add to My Bibliography
- My Bibliography
Your saved search
Name of saved search: Search terms: Test search terms Would you like email updates of new search results? Saved Search Alert Radio Buttons- Yes
- No
Create a file for external citation management software
Create file CancelYour RSS Feed
Name of RSS Feed: Number of items displayed: 5 10 15 20 50 100 Create RSS Cancel RSS Link CopyFull text links
Elsevier Science Full text links Actions
CiteCollectionsAdd to Collections- Create a new collection
- Add to an existing collection
Page navigation
- Title & authors
- Abstract
- Publication types
- MeSH terms
- Substances
- LinkOut - more resources
Abstract
The objective of the study was to evaluate the efficacy and safety of 800 microg misoprostol (Cytotec) every 8 h for 24 h for pharmacological abortion; the treatment was repeated if abortion did not occur in the first 24-h interval. The first misoprostol doses were always self-administered into the vagina; the second and third doses could be administered orally or vaginally depending on the amount of bleeding. Four-hundred and fifty-two women with gestations between 36 and 63 days were recruited into the study. The main outcomes assessed were: successful abortion (complete abortion without surgery), side effects, mean drop in hemoglobin, vaginal bleeding and mean time of return of menstruation. Complete abortion occurred in 409/452 (90.5%; 95% confidence interval [CI] 87%, 93%) patients. Medication to relieve symptoms was administered to all women before the first misoprostol dose. Vaginal bleeding lasted 15.9 +/- 4.4 days. The mean drop in hemoglobin, measured 14 days after abortion, was statistically significant (p = 0.0001) but without clinical relevance. According to the results obtained, 800 microg of misoprostol administered every 8 h for 24 h could be a valid method for abortion for up to 9 weeks of gestation.
PubMed Disclaimer
Publication types
- Clinical Trial Actions
- Search in PubMed
- Search in MeSH
- Add to Search
MeSH terms
- Abortifacient Agents, Nonsteroidal / administration & dosage* Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Abortifacient Agents, Nonsteroidal / adverse effects Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Abortion, Induced / methods* Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Administration, Intravaginal Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Administration, Oral Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Female Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Gestational Age Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Humans Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Logistic Models Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Misoprostol / administration & dosage* Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Misoprostol / adverse effects Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Pain Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Patient Satisfaction Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Pregnancy Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Self Administration Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Time Factors Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Treatment Outcome Actions
- Search in PubMed
- Search in MeSH
- Add to Search
Substances
- Abortifacient Agents, Nonsteroidal Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Misoprostol Actions
- Search in PubMed
- Search in MeSH
- Add to Search
LinkOut - more resources
Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information
Elsevier Science [x] Cite Copy Download .nbib .nbib Format: AMA APA MLA NLM Send To - Clipboard
- Save
- My Bibliography
- Collections
- Citation Manager
NCBI Literature Resources
MeSH PMC Bookshelf Disclaimer
The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.
Tag » How Many Tablets Of Misoprostol Should Be Inserted
-
Instructions For The Self-administration Of Vaginal Misoprostol At ...
-
[PDF] Preparing For Your Procedure With Misoprostol
-
[PDF] Instructions For Using Vaginal Misoprostol In Medical Abortion
-
5 Things To Know About Misoprostol For Early Pregnancy Loss ...
-
Are There Other Ways To Use The Misoprostol? - Women On Waves
-
Comparing Buccal And Vaginal Misoprostol In Management Of Early ...
-
How Do I Use The Abortion Pill? - Planned Parenthood
-
[PDF] Treatment Of Miscarriage With Misoprostol/Cytotec
-
Vaginal Misoprostol Administered 1, 2, Or 3 Days After Mifepristone ...
-
How Should I Take The Misoprostol Pills?
-
How To Buy Abortion Pills That Are Safe And Effective - Ipas
-
Mifepristone (Oral Route) Proper Use - Mayo Clinic
-
Home Self-administration Of Vaginal Misoprostol For Medical Abortion ...
-
How To Use The Abortion Pill - Verywell Health